Innovative Community Oncology Practices Selects Deep Lens’ VIPER™ as Preferred Clinical Trial Matching Solution for Network
Retrieved on:
Friday, July 30, 2021
Other Health, Other Science, Pharmaceutical, Other Technology, Research, Oncology, Software, Medical devices, Hospitals, Data management, Science, Technology, Practice Management, Clinical trials, Managed care, General Health, Biotechnology, Health, Oncology, Innovative Community Oncology Practices, Deep Lens, INNOVATIVE COMMUNITY ONCOLOGY PRACTICES, DEEP LENS
Deep Lens and the Innovative Community Oncology Practices ( ICOP ) today announced a strategic partnership that will position Deep Lens VIPER as the preferred clinical trial program management technology solution for the 13-practice, U.S.-based network.
Key Points:
- Deep Lens and the Innovative Community Oncology Practices ( ICOP ) today announced a strategic partnership that will position Deep Lens VIPER as the preferred clinical trial program management technology solution for the 13-practice, U.S.-based network.
- VIPER is an artificial intelligence-based solution that matches eligible patients to clinical trials right at the time of diagnosis.
- Through this agreement, VIPER and other Deep Lens services will become available to all ICOP practices.
- Innovative Community Oncology Practices (ICOP) is a conglomerate of 13 oncology practices nationwide designed to increase the scope of services and activities in the community oncology setting.